The available information on breast cancer has evolved so rapidly that a textbook understanding is no longer sufficient to make sound therapeutic decisions. Further, the latest findings and data are spread throughout the scientific literature of various medical fields, making it difficult for medical professionals to keep abreast of these advances, and to apply them in their day-to-day work. This book provides updated information on breast cancer, such as the modern molecular classification and staging, and demonstrates how imaging with pathologic correlation can be used in management decisions. In addition, it identifies the most suitable imaging modalities for screening, diagnosis and monitoring for each clinical case. Given its scope, the book offers a valuable resource for all medical professionals (practicing or still in training) whose work involves breast cancer, including radiologists, breast surgeons, pathologists, radiotherapists and nuclear medicine professionals.

This superbly illustrated book provides a thorough, up-to-date overview of diagnostic breast imaging and therapy. Drs. Elizabeth Morris, Michael Fuchsjäger, and Thomas Helbich, three experts in the field, have collaborated with colleagues from their institutions and selected medical centers to share their expertise. The coverage ranges from basic information on imaging technologies and interventional equipment and how to use them optimally to the application of advanced high-end techniques for screening and assessment in any given professional environment. Readers will find clear instruction on the various breast interventional procedures guided by stereotaxis, ultrasound, and magnetic resonance imaging in wide clinical use. The management of patients with ductal carcinoma in situ and high-risk breast cancer is considered separately. Furthermore, the role of minimally invasive therapy is examined, and advice is provided on post-therapy evaluation, including breast implants. A comprehensive diagnostic atlas with hundreds of images completes this volume and addresses the spectrum of various clinical situations.

Cancer cells dedifferentiate with repect to cell function; their vascularity is more leaky, but perfusion is heterogenerously reduced, and interstitial fluid pressure is high, severely retarding delivery of agents from the blood. Targeted imaging is designed to produce a detectable difference between tissue that is visualized with single photon and positron emission tomography, magnetic resonance imaging, computed tomography, or ultrasonography. This book uniquely reports strategies for the application of molecular targeted imaging agents such as antibodies, peptides, receptors and contrast agents in the biologic grading of tumors, differential diagnosis of tumors, prediction of therapeutic response and monitoring tumor response to treatment. This book also describes updated information about the imaging of tumor angiogenesis, hypoxia, apoptosis and gene delivery as well as expression in the understanding and utility of tumor molecular biology for better cancer management.

During the past decade significant developments have been achieved in the field of magnetic resonance imaging (MRI), enabling MRI to enter the clinical arena of chest imaging. Standard protocols can now be implemented on up-to-date scanners, allowing MRI to be used as a first-line imaging modality for various lung diseases, including cystic fibrosis, pulmonary hypertension and even lung cancer. The diagnostic benefits stem from the ability of MRI to visualize changes in lung structure while simultaneously imaging different aspects of lung function, such as perfusion, respiratory motion, ventilation and gas exchange. On this basis, novel quantitative surrogates for lung function can be obtained. This book provides a comprehensive overview of how to use MRI for imaging of lung disease. Special emphasis is placed on benign diseases requiring regular monitoring, given that it is patients with these diseases who derive the greatest benefit from the avoidance of ionizing radiation.

Reporter genes have been used for several decades to study regulation of gene expression in vivo. However, it was little more than a decade ago that a new class of reporter genes was developed for imaging molecular events within living subjects. By following the interactions of protein molecules, researchers can resolve the complex chemical pathways that living cells utilise. This book focuses on this group of imaging reporter genes, starting with detailed descriptions of all reporter genes from different imaging modalities, including optical, MRI, and radionuclide-based imaging. Key scientists in the field explain how to enhance reporter gene imaging utility through instrumentation and the various applications of this technology. This is the first comprehensive book on all aspects of reporter gene imaging, detailing what is known in the field and future goals for research. Investigators in biomedical sciences, physicians, and the biotechnology and pharmaceutical industries will benefit from topics covered.

This book describes current examination techniques and advanced clinical applications of state-of-the-art multidetector computed tomography (MDCT) scanners. There are contributions from several distinguished radiologists and clinicians. Each chapter is written from a practical perspective, so that radiologists, residents, medical physicists, and radiology technologists can obtain relevant information about MDCT applications.

SPIE Milestones are collections of seminal papers from the world literature covering important discoveries and developments in optics and photonics.